Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trialsNicola Potter, Richard Dillon, Adam Ivey et al.|The Lancet Haematology|2025Cited by 9
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significanceMeryem Ozgencil, Ellen Solomon|PLoS ONE|2021Cited by 3